Signal Bay Inc (OTCMKTS:SGBY)

Signal Bay Inc (OTCMKTS:SGBY) Into Florida After California

Signal Bay Inc (OTCMKTS:SGBY)

Signal Bay Inc (OTCMKTS:SGBY) was up by 1.13% in Monday’s trading session after announcing the expansion of its EVIO labs into Florida. The expansion comes days after the company expanded its footprint into Southern California in pursuit of new opportunities for their analytical testing services.

Signal Bay Inc (OTCMKTS:SGBY)
One month daily candlebar chart for $SGBY

Florida Expansion

In Florida, Kaycha Holdings will provide EVIO Labs services as part of licensing agreement. Expansion in Florida, according to Chief executive officer William Waldrop, should allow the company to continue executing on its core mission of providing clean cannabis to patients.

“Our Florida expansion also marks another first as we executed our first license agreement. We are excited to have found a partner with deep ties to the community and shares our common core values,” said Mr. Waldrop.

Signal Bay Inc. (OTCMKTS:SGBY), through its subsidiary, provides analytical testing services as well as scientific research on matters pertaining to legal cannabis. The company also operates state of the art testing facilities that verify the safety and potency of the nation’s cannabis supply.

Signal Bay Inc (OTCMKTS:SGBY) has operations in California, Oregon, and Florida as it continues to pursue licensing agreements in other states that have also approved medical marijuana. Expansion into Southern California presents the company an opportunity to target a market that is growing robustly and expected to be worth $6.46 billion by 2020.

Massachusetts is another target market that the company has set its eyes on. Recently it’s signed a definitive agreement for the acquisition of Viridis Analytics MA. The acquisition is one of a handful of cannabis testing laboratories in the state, serving clients from its headquarters in Southborough.

Growing demand for testing Services

Cannabis’ legalization drive has led to an increase in demand for marijuana products for both medicinal and recreational purposes. Increased consumption has led to an uptick in calls for lawmakers to enact regulations that ensure the safety of marijuana products in the market.

Demand for accredited testing services is expected to continue growing and presenting unique opportunities that Signal Bay Inc. (OTCMKTS:SGBY) can tap into. Massachusetts’ cannabis testing market alone could grow to highs of $30 million by 2020.

“We have cutting edge testing equipment, the expertise, gravitas and a head start on competition in what are expected to be massive markets, As we cement our positions in these markets, our strategy is to identify optimal organic and inorganic growth opportunities to cascade our labs across the country,” said Mr. Waldrop.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $SGBY and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)

Will OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Halt Slide?

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)

Shares of OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) gained 4.50% last Friday, but still were at levels unseen since early January of 2017. Share volume was heavy – about 75% over their 30-day daily average of 1.2 million. Over two million shares traded hands with a notional value of over $700,000.

$OWCP Graph
One World Cannabis One Month Daily Candlebar Graph

One World Cannabis Ltd. (OWC) is a wholly owned subsidiary of OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) and discovers and develops cannabis-based therapies and treatments for ilnesses including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing proprietary delivery systems for the delivery and dosage of medical-grade cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions. OWC has two divisions – research and consulting. Its research division pursues clinical trials that will evaluate the effectiveness of cannabinoids for the treatment of various medical conditions. OWC’s consulting division assists governments and private entities create and navigate legal cannabis regulatory frameworks on a global basis.

At the beginning of 2017, shares of OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) began rocketing up from under $0.20 per share to, by the end of February, over $3.20 per share. The catalyst for the gains was a number of appointments to key posts in the company followed by the company receiving the Israeli Institutional Review Board’s (IRB) approval to conduct safety testing on its proprietary topical creme compound for the treatment of psoriasis and related skin conditions. That news followed a U.S. SEC 8K filing announcing an extension to the size and scope of its efficacy study on the same compound, which began in November 2106.

However, since that time, OWCP shareholders have lost interest and last week OWCP shares began trading under $0.40 per share. Some observers believe that OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) may have a tough time creating a commercially viable product to generate revenues. Cannabinoid-based creams to treat skin ailments have existed for some time but without scientific study to back them up. OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is now pursuing clinical trials that would, hopefully, confirm the safety and efficacy of such a treatment. However, should One World Cannabis prove the science, what is to stop existing cannabinoid-based creams from piggy-backing on the results for a fraction of the cost as they had no such expense to absorb?

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $OWCP and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.

Acquired! North American Cannabis Holdings, Inc. (USOTC:USMJ) and Puration Inc (OTCMKTS:PURA)

Puration Inc (OTCMKTS:PURA)North American Cannabis Holdings, Inc. (USOTC:USMJ)

Puration Inc (OTCMKTS:PURA) has entered into a letter-of-intent (LOI) to sell controlling interest to American Cannabis Innovations Conglomerated (ACI). Included in the press release was also the news that ACI will be acquiring controlling interest of North American Cannabis Holdings, Inc. (USOTC:USMJ). ACI is a private-equity backed company founded to combine a variety of leading young cannabis companies with complimentary offerings and synergistic operations all under one roof. North American Cannabis Holdings, Inc. (USOTC:USMJ) and Puration Inc (OTCMKTS:PURA)  are the first cannabis-sector acquisitions ACI plans to announce in the next 30 days.  Reports claim that there may be as many as three more in the pipeline. ACI is seeking to acquire early-stage, undervalued businesses with market-validated intellectual properties validated by market tests.  ACI expects to improve the acquisition’s operating efficiency by eliminating redundant functions, leveraging complimentary functions, and obtaining better financial terms than currently exist.

Existing North American Cannabis Holdings, Inc. (USOTC:USMJ) and Puration Inc (OTCMKTS:PURA) management are expected to continue in their current responsibilities. Final shareholder approval of the deals is to be completed by the end of this month.

Interestingly, Puration Inc (OTCMKTS:PURA) acquired some operating assets from North American Cannabis Holdings, Inc. (USOTC:USMJ) in July of 2016. Puration then proceeded to develop processes that would result in high-quality cannabinoid concentrates targeting the social user and health and wellness sector.

North American Cannabis Holdings, Inc. (USOTC:USMJ), in 2013, began its operations in the cannabis sector through a subsidiary named The American Seed & Oil Company. This company was formed to explore commercial opportunities in the legal cannabis sector. More recently, North American Cannabis Holdings, Inc. (USOTC:USMJ) introduced the AmeriCanna Café, a destination beverage company  featuring cannabis infused beverages. The company al;ready markets a cannabis infused “shot” branded “DuBe Hemp Energy”.

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance